DRIVING NATURAL KILLER CELL IMMUNOTHERAPY IN THE CASTRATION-RESISTANT PROSTATE CANCER SETTING WITH NOVEL TRISPECIFIC KILLER ENGAGER MOLECULES

Regents Of The University Of Minnesota

Investigators